![]() Inflazome Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome. | ![]() SiteOne Therapeutics SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders. | |
Founding Date | Founding Date 2016 | Founding Date 2014 |
Type | Type Subsidiary | Type Private |
Tags | ||
Locations | Locations Dublin 2, IE HQ Brisbane City, AU Cambridge, GB | Locations San Francisco, US HQ Bozeman, US |
Employees | Employees 156% decrease | Employees 2216% increase |
Funding | ||
Total funding raised | Total funding raised $ 17m | Total funding raised $ 17.8m |

SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders.
View company